Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Más filtros












Base de datos
Intervalo de año de publicación
1.
Orthop Surg ; 12(6): 1963-1970, 2020 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-33078894

RESUMEN

OBJECTIVE: To demonstrate the expression of abnormal spindle microtubule assembly (ASPM) in clinical osteosarcoma tissue specimens collected in our hospital, and to explore the function of ASPM in osteosarcoma in vitro and in vivo. METHODS: Tissue specimens from 82 cases of osteosarcoma were collected and analyzed by immunohistochemistry assay. We also investigated the relationship between ASPM expression and clinicopathological characteristics in the patients. We transfected shASPM plasmid and the empty control plasmid, respectively, and then used quantitative polymerase chain reaction and western blot analysis to detect ASPM expression. Cell colony assay and MTT were used to observe the proliferation ability. In vivo study was undertaken to explore the ASPM function further. RESULTS: In this study, ASPM showed high expression in osteosarcoma tissue samples compared with non-tumor normal tissues. ASPM was positively correlated with clinical pathological characteristics, including tumor size (P = 0.024) and clinical stage (P = 0.045). Our results further showed that ASPM depletion dramatically inhibited the proliferation of osteosarcoma cells (with fewer cells in the sh-RNA-ASPM group compared with the control group(P < 0.05, respectively), and the in vivo assays further confirmed that ASPM ablation markedly blocked tumor growth compared with control (P < 0.05). CONCLUSION: Our data provides strong evidence that the high expression of ASPM in osteosarcoma promotes proliferation in vitro and in vivo, indicating its potential role as an osteosarcoma therapeutic target.


Asunto(s)
Neoplasias Óseas/metabolismo , Proteínas Asociadas a Microtúbulos/metabolismo , Terapia Molecular Dirigida/métodos , Proteínas del Tejido Nervioso/metabolismo , Proteínas del Tejido Nervioso/farmacología , Osteogénesis/efectos de los fármacos , Osteosarcoma/metabolismo , Animales , Línea Celular Tumoral , Proliferación Celular , Progresión de la Enfermedad , Femenino , Humanos , Masculino , Ratones , Ratones Endogámicos BALB C , Ratones Desnudos , ARN Interferente Pequeño/fisiología , Transfección , Carga Tumoral
2.
Mitochondrial DNA A DNA Mapp Seq Anal ; 27(3): 1804-5, 2016 05.
Artículo en Inglés | MEDLINE | ID: mdl-25317643

RESUMEN

We sequenced a diabetic Rattus norvegicus Wistar strain mitochondrial genome for the first time (GenBank Accession No. KM114608). Its mitogenome was 16,311 bp and coding 13 protein-coding genes, 2 ribosomal RNA genes, 22 transfer RNA genes. This mitogenome sequence will provide definite genetic information for diabetes disease.


Asunto(s)
Diabetes Mellitus/genética , Genoma Mitocondrial , Animales , Composición de Base/genética , Emparejamiento Base/genética , Secuencia de Bases , ADN Mitocondrial/genética , Modelos Animales de Enfermedad , Orden Génico , Masculino , Polimorfismo de Nucleótido Simple/genética , Ratas Wistar
3.
Mitochondrial DNA A DNA Mapp Seq Anal ; 27(3): 1997-8, 2016 05.
Artículo en Inglés | MEDLINE | ID: mdl-25350740

RESUMEN

In the present work we undertook the complete mitochondrial genome sequencing of an important insulin resistance model inbred rat strain for the first time. The total length of the mitogenome was 16,308 bp. It harbored 13 protein-coding genes, 2 ribosomal RNA genes, 22 transfer RNA genes and 1 non-coding control region (D-loop region). The mutation events were also reported.


Asunto(s)
Genoma Mitocondrial , Resistencia a la Insulina/genética , Mutación/genética , Animales , Secuencia de Bases , Modelos Animales de Enfermedad , Genes Mitocondriales , Ratones Endogámicos C57BL , ARN de Transferencia/genética
4.
Chin Med J (Engl) ; 122(24): 2973-6, 2009 Dec 20.
Artículo en Inglés | MEDLINE | ID: mdl-20137484

RESUMEN

BACKGROUND: If the emphysema lesions are not symmetrical, unilateral lung volume reduction surgery (LVRS) can be carried out on the more severe side. The aim of this research was to evaluate the feasibility and effects of LVRS performed simultaneously with resection of pulmonary and esophageal neoplasms. METHODS: Forty-five patients with pulmonary neoplasm and 37 patients with esophageal neoplasm were randomly assigned to group A or group B. In group A, LVRS was performed simultaneously on the same side as thoracotomy. In group B, only tumor resection was performed. The nonfunctional lung area was determined by preoperative chest computed tomography and lung ventilation/perfusion scan. The lung volume removed was about 20% to 30% of the lobes on one side. Preoperative and postoperative indexes including pulmonary function testing variables, arterial blood gas analysis variables, dyspnea scale, 6-minute walk distance, etc., were compared between the groups. RESULTS: There were no surgical deaths in this study. The postoperative forced vital capacity in 1 second, PaO2, PaCO2, dyspnea scale, and 6-minute walk distance were improved significantly in group A, whereas these indexes did not change or decreased slightly in group B. CONCLUSIONS: For tumor patients who have associated emphysema, simultaneous LVRS not only increases the chance of receiving surgical therapy, but also improves the postoperative quality of life of the patient. LVRS has expanded the surgical indication for tumor patients.


Asunto(s)
Neoplasias Esofágicas/cirugía , Neoplasias Pulmonares/cirugía , Neumonectomía/métodos , Adulto , Femenino , Humanos , Masculino , Persona de Mediana Edad , Enfisema Pulmonar/cirugía , Toracotomía/métodos , Resultado del Tratamiento
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...